Division of Nutrition and Dietetics, School of Health Sciences, International Medical University, Kuala Lumpur, Malaysia.
Division of Endocrinology, Diabetes and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, United States of America.
PLoS One. 2020 Nov 30;15(11):e0242487. doi: 10.1371/journal.pone.0242487. eCollection 2020.
Eating self-efficacy behavior is an important predictor of successful lifestyle intervention. This secondary analysis evaluated the changes in eating self-efficacy behavior in patients with type 2 diabetes (T2D) and overweight/obesity following structured lifestyle intervention based on the Malaysian customized transcultural Diabetes Nutrition Algorithm (tDNA).
Patients with T2D and overweight/obesity (n = 230) were randomized either into the tDNA group which included a structured low-calorie meal plan using normal foods, incorporation of diabetes-specific meal replacements, and an exercise prescription or usual T2D care (UC) for 6 months. Patients in the tDNA group also received either counseling with motivational interviewing (tDNA-MI) or conventional counseling (tDNA-CC). The UC group received standard dietary and exercise advice using conventional counseling. Eating self-efficacy was assessed using a locally validated Weight Efficacy Lifestyle (WEL) questionnaire. All patients were followed up for additional 6 months' post-intervention.
There was a significant change in WEL scores with intervention over one-year [Group X Time effect: F = 51.4, df = (3.4, 318.7), p<0.001]. Compared to baseline, WEL scores improved in both the tDNA groups with significantly higher improvement in the tDNA-MI group compared to the tDNA-CC and UC groups at 6 months (tDNA-MI: 25.4±2.1 vs. tDNA-CC: 12.9±2.8 vs. UC: -6.9±1.9, p<0.001). At 12 months' follow-up, both the tDNA groups maintained improvement in the WEL scores, with significantly higher scores in the tDNA-MI group than tDNA-CC group, and the UC group had decreased WEL scores (tDNA-MI: 28.9±3.1 vs. tDNA-CC: 11.6±3.6 vs. UC: -13.2±2.1, p<0.001). Patients in the tDNA-MI group with greater weight loss and hemoglobin A1C reduction also had a higher eating self-efficacy, with a similar trend observed in comparative groups.
Eating self-efficacy improved in patients with T2D and overweight/obesity who maintained their weight loss and glycemic control following a structured lifestyle intervention based on the Malaysian customized tDNA and the improvement was further enhanced with motivational interviewing.
This randomized clinical trial was registered under National Medical Research Registry, Ministry of Health Malaysia with registration number: NMRR-14-1042-19455 and also under ClinicalTrials.gov with registration number: NCT03881540.
饮食自我效能行为是成功生活方式干预的重要预测指标。本二次分析评估了基于马来西亚定制跨文化糖尿病营养算法(tDNA)的结构化生活方式干预后 2 型糖尿病(T2D)和超重/肥胖患者饮食自我效能行为的变化。
将 230 名 T2D 和超重/肥胖患者随机分为 tDNA 组或常规治疗组(UC),每组 115 例。tDNA 组患者接受结构化低热量膳食计划,使用普通食物,加入糖尿病专用膳食替代品,并开运动处方,或接受常规 T2D 护理(UC),为期 6 个月。tDNA 组患者还接受了动机访谈(tDNA-MI)或常规咨询(tDNA-CC)的咨询。UC 组接受常规咨询,提供标准饮食和运动建议。使用本地验证的体重效能生活方式(WEL)问卷评估饮食自我效能。所有患者在干预后额外随访 6 个月。
在一年的时间里,WEL 评分随干预而变化[组间时间效应:F = 51.4,df =(3.4,318.7),p<0.001]。与基线相比,tDNA 组的 WEL 评分均有所提高,tDNA-MI 组的改善明显高于 tDNA-CC 组和 UC 组,6 个月时分别为 25.4±2.1、12.9±2.8 和-6.9±1.9(p<0.001)。在 12 个月的随访中,tDNA 组均保持 WEL 评分的改善,tDNA-MI 组的评分明显高于 tDNA-CC 组,UC 组的评分则下降(tDNA-MI:28.9±3.1、tDNA-CC:11.6±3.6、UC:-13.2±2.1,p<0.001)。在基于马来西亚定制 tDNA 的结构化生活方式干预后,体重减轻和糖化血红蛋白降低的 tDNA-MI 组患者的饮食自我效能也有所提高,且在比较组中也观察到了类似的趋势。
基于马来西亚定制 tDNA 的结构化生活方式干预后,体重减轻和血糖控制得以维持的 2 型糖尿病和超重/肥胖患者的饮食自我效能有所提高,动机访谈进一步增强了这种改善。
这项随机临床试验在马来西亚卫生部国家医学研究登记处注册,注册号为 NMRR-14-1042-19455,也在美国临床试验注册处注册,注册号为 NCT03881540。